chr15-28229535-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BP4_Strong
The NM_004667.6(HERC2):āc.5045A>Gā(p.Asn1682Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00014 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_004667.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HERC2 | NM_004667.6 | c.5045A>G | p.Asn1682Ser | missense_variant | 33/93 | ENST00000261609.13 | NP_004658.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HERC2 | ENST00000261609.13 | c.5045A>G | p.Asn1682Ser | missense_variant | 33/93 | 1 | NM_004667.6 | ENSP00000261609.8 | ||
HERC2 | ENST00000569335.1 | n.-19A>G | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250984Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135722
GnomAD4 exome AF: 0.000148 AC: 216AN: 1461542Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 117AN XY: 727100
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74380
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2021 | The c.5045A>G (p.N1682S) alteration is located in exon 33 (coding exon 32) of the HERC2 gene. This alteration results from a A to G substitution at nucleotide position 5045, causing the asparagine (N) at amino acid position 1682 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Dystonic disorder;C0035410:Rhabdomyolysis;C0152115:Orofacial dyskinesia;C0241005:Elevated circulating creatine kinase concentration;C0427086:Involuntary movements;C0557874:Global developmental delay;C3489733:Oculomotor apraxia;C4021822:Abnormal female external genitalia morphology;C4022715:Hypoplastic female external genitalia;C4025706:Abnormal globus pallidus morphology Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Personalized Medicine, Children's Hospital Los Angeles | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at